NYSE:COR

Cencora Stock Insider Trading

> Medical - Distribution

Buy COR

*Your capital is at risk

$281.10

+9.82 (+3.62%)

At Close: Jun 23, 2026

Cencora Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -7.49. In total, the insiders bought 37.72M and sold 131.77K COR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-7.49
● Buy	37.72M shares
● Sell	131.77K shares
70% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Jun 18, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 18, 2026 Buy	Common Stock P-Purchase	Durcan Dermot Mark Director	Director	4 000 Value: $1.10M
May 28, 2026 Buy	Common Stock P-Purchase	Durcan Dermot Mark Director	Director	4 000 Value: $1.07M
May 01, 2026 Buy	Common Stock A-Award	Cooper Ellen Director	Director	99 Value: $30.1K
May 01, 2026 Buy	Common Stock A-Award	Nally Dennis M Director	Director	116 Value: $35.3K
May 01, 2026 Buy	Common Stock A-Award	Tyler Lauren M Director	Director	99 Value: $30.1K
Apr 01, 2026 Buy	Restricted Stock Units A-Award	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	3 936 Value: $1.25M
Mar 11, 2026 Buy	Common Stock M-Exempt	Battaglia Silvana Executive Vice President	CEO / President	8 415 Value: $2.95M
Mar 11, 2026 Sell	Common Stock F-InKind	Battaglia Silvana Executive Vice President	CEO / President	3 673 Value: $1.29M
Mar 11, 2026 Buy	Restricted Stock Units M-Exempt	Battaglia Silvana Executive Vice President	CEO / President	8 415 Value: $2.95M
Mar 11, 2026 Buy	Common Stock M-Exempt	Campbell Elizabeth S Executive Vice President	CEO / President	12 623 Value: $4.42M
Mar 11, 2026 Sell	Common Stock F-InKind	Campbell Elizabeth S Executive Vice President	CEO / President	5 842 Value: $2.05M
Mar 11, 2026 Buy	Restricted Stock Units M-Exempt	Cleary James F Chief Financial Officer	C-Suite Officer	12 623 Value: $4.42M
Mar 11, 2026 Sell	Common Stock F-InKind	Cleary James F Chief Financial Officer	C-Suite Officer	5 409 Value: $1.89M
Mar 11, 2026 Buy	Common Stock M-Exempt	Cleary James F Chief Financial Officer	C-Suite Officer	12 623 Value: $4.42M
Mar 11, 2026 Buy	Restricted Stock Units M-Exempt	Campbell Elizabeth S Executive Vice President	CEO / President	12 623 Value: $4.42M
Mar 05, 2026 Buy	Common Stock A-Award	Baumann Werner Director	Director	557 Value: $200.1K
Mar 05, 2026 Buy	Common Stock A-Award	Durcan Dermot Mark Director	Director	905 Value: $325.1K
Mar 05, 2026 Buy	Common Stock A-Award	Greenberg Lon R Director	Director	557 Value: $200.1K
Mar 05, 2026 Buy	Common Stock A-Award	Ryerkerk Lori Director	Director	557 Value: $200.1K
Mar 05, 2026 Buy	Common Stock A-Award	Cooper Ellen Director	Director	557 Value: $200.1K
Mar 05, 2026 Buy	Common Stock A-Award	Miller Redonda Director	Director	557 Value: $200.1K
Mar 05, 2026 Buy	Common Stock A-Award	Kim Lorence H. Director	Director	557 Value: $200.1K
Mar 05, 2026 Buy	Common Stock A-Award	Clyburn Frank Director	Director	557 Value: $200.1K
Mar 05, 2026 Buy	Common Stock A-Award	Tyler Lauren M Director	Director	557 Value: $200.1K
Mar 05, 2026 Buy	Common Stock A-Award	Nally Dennis M Director	Director	557 Value: $200.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CENCORA INC.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alt...

Read Full Profile Here